What is ORIC Pharmaceuticals, Inc. (ORIC)?
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted therapies for cancer treatment. The company’s research and development efforts concentrate on advancing novel drug candidates designed to address unmet medical needs in oncology. Its pipeline includes product candidates aimed at improving efficacy and safety profiles compared to existing treatments. The company employs a precision medicine approach, leveraging insights into tumor biology and patient selection to optimize therapeutic outcomes. It collaborates with academic institutions and industry partners to support its clinical programs. The company operates within the regulatory framework governing drug development and clinical trials.
ORIC Pharmaceuticals, Inc. Stock Price Today: Live Overview
The price today is shaped by active trading, as ORIC Pharmaceuticals, Inc. trades at $12.26. The intraday session has seen prices between $11.66 and $12.37, with a daily change of +1.6878%.
FAQ: ORIC Pharmaceuticals, Inc. (ORIC)
What is the current price of ORIC stock?
The stock is currently priced at $12.26.
Does ORIC pay dividends?
Dividends are not paid by this company.
Does ORIC have a formal corporate presence or regional headquarters in the UAE?
ORIC Pharmaceuticals, Inc. has no official regional office or subsidiary in the UAE and operates through partners only.
What is ORIC best known for?
The company is most famous for developing oncology and immunology therapies.
What assets are typically shown together with ORIC?
Commonly shown alongside ORIC: Stoke Therapeutics, Inc., Axsome Therapeutics Inc, Lineage Inc
Latest shares articles



